Stock CRXM GENE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Gene Biotherapeutics, Inc.

Equities

CRXM

US8767671048

Market Closed - OTC Markets
Other stock markets
 16:03:37 22/05/2024 BST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Gene Biotherapeutics, Inc. -.--% -.--%
2022 Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt CI
2021 Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GENE BIOTHERAPEUTICS, INC. Stock Gene Biotherapeutics, Inc.
 64 - - - - -
MODERNA, INC. Stock Moderna, Inc.
 57.87B -
LONZA GROUP AG Stock Lonza Group AG
 40.25B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.94B
CELLTRION, INC. Stock Celltrion, Inc.
 28.54B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.4B
  1. Stock Market
  2. Equities
  3. CRXM Stock
  4. Charts Gene Biotherapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW